MERRITT STEVENSON: Open Payments
NPI 1417297029 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,825 in 115 payments from 17 companies in 2025. Trend: 2023 $1,192 · 2024 $1,525 · 2025 $3,825
Food & beverage: $3,825
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $1,284 |
| Janssen Biotech, Inc. | 9 | $567 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $455 |
| Madrigal Pharmaceuticals | 6 | $327 |
| Regeneron Healthcare Solutions, Inc. | 8 | $230 |
| Lilly USA, LLC | 7 | $198 |
| Medtronic, Inc. | 2 | $168 |
| Phathom Pharmaceuticals, Inc. | 4 | $160 |
| Ardelyx, Inc. | 7 | $132 |
| Aimmune Therapeutics, Inc. | 4 | $72 |
Products named: SKYRIZI, TREMFYA, XIFAXAN, REZDIFFRA, RINVOQ, DUPIXENT, CREON, OMVOH.
Industry payments across SC — which companies pay providers there.
